EX-10.3 3 dex103.htm AMENDED AND RESTATED MANUFACTURING AGREEMENT *Confidential Treatment has been requested for the marked portions of this exhibit pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. AMENDED AND RESTATED...Manufacturing Agreement • May 5th, 2020 • California
Contract Type FiledMay 5th, 2020 JurisdictionTHIS AMENDED AND RESTATED MANUFACTURING AGREEMENT (the “Agreement”) is made effective as of February 25, 2009 (the “Amendment Date”) by and between CELLADON CORPORATION, a California corporation, with its principal place of business at 2223 Avenida de la Playa, Suite 300, c/o Enterprise Partners Venture Capital, La Jolla, CA 92037 (“Celladon”), and TARGETED GENETICS CORPORATION, a Washington corporation with its principal offices at 1100 Olive Way, Suite 100, Seattle, Washington 98101 (“TGC”).
AMENDED AND RESTATED MANUFACTURING AGREEMENTManufacturing Agreement • May 7th, 2009 • Targeted Genetics Corp /Wa/ • Biological products, (no disgnostic substances) • California
Contract Type FiledMay 7th, 2009 Company Industry JurisdictionTHIS AMENDED AND RESTATED MANUFACTURING AGREEMENT (the “Agreement”) is made effective as of February 25, 2009 (the “Amendment Date”) by and between CELLADON CORPORATION, a California corporation, with its principal place of business at 2223 Avenida de la Playa, Suite 300, c/o Enterprise Partners Venture Capital, La Jolla, CA 92037 (“Celladon”), and TARGETED GENETICS CORPORATION, a Washington corporation with its principal offices at 1100 Olive Way, Suite 100, Seattle, Washington 98101 (“TGC”).